BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 20821873)

  • 1. The significance of the International Normalized Ratio (INR) for oral anticoagulant therapy.
    van den Besselaar AM
    J Int Fed Clin Chem; 1991 Sep; 3(4):146-53. PubMed ID: 20821873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Standardization of coagulation tests.
    Opartkiattikul N
    Southeast Asian J Trop Med Public Health; 1999; 30 Suppl 3():79-85. PubMed ID: 10926265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International standardization of laboratory control of oral anticoagulant therapy: a survey of thromboplastin reagents used for prothrombin time testing.
    van den Besselaar AM
    J Heart Valve Dis; 1993 Jan; 2(1):42-52. PubMed ID: 8269109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
    Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
    Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Precision and accuracy of the international normalized ratio in oral anticoagulant control.
    van den Besselaar AM
    Haemostasis; 1996 Oct; 26 Suppl 4():248-65. PubMed ID: 8979131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reliability and clinical impact of the normalization of the prothrombin times in oral anticoagulant control.
    Loeliger EA; van den Besselaar AM; Lewis SM
    Thromb Haemost; 1985 Feb; 53(1):148-54. PubMed ID: 3992514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Questions and answers on prothrombin time standardisation in oral anticoagulant control.
    Loeliger EA; Poller L; Samama M; Thomson JM; Van den Besselaar AM; Vermylen J; Verstraete M
    Thromb Haemost; 1985 Aug; 54(2):515-7. PubMed ID: 4082086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral anticoagulant therapy control: evidence that INR expression improves the inter-laboratory comparability of results--the Bologna oral anticoagulant control exercise.
    Palareti G; Coccheri S; Poggi M; Bonetti M; Cervi V; Mazzuca A; Savoia M; Veri L; Fiori F; Gaspari G
    Thromb Haemost; 1987 Oct; 58(3):905-10. PubMed ID: 3433253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defining a metrologically traceable and sustainable calibration hierarchy of international normalized ratio for monitoring of vitamin K antagonist treatment in accordance with International Organization for Standardization (ISO) 17511:2020 standard: communication from the International Federation of Clinical Chemistry and Laboratory Medicine-SSC/ISTH working group on prothrombin time/international normalized ratio standardization.
    van den Besselaar AMHP; Stavelin A; Kitchen S; Bryant M; Tripodi A; Scalambrino E; Clerici M; Herbel P; Jünschke A; Meyer Dos Santos S; Meijer P; Niessen RWLM; Meijers JCM; Thelwell C; Cuker A; Kung C; Cao Z; Zander N; Iwasaki Y; Depasse F; van Rijn C; Baktawar S; Abdoel C; Cobbaert CM
    J Thromb Haemost; 2024 Apr; 22(4):1236-1248. PubMed ID: 38128762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Control of oral anticoagulation. Current concepts].
    Aguilar CA; Hurtado Monroy R; Gaspar Hernández J
    Rev Invest Clin; 1989; 41(4):371-4. PubMed ID: 2698502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of EDTA samples for prothrombin time measurement in patients receiving oral anticoagulants.
    Horsti J
    Haematologica; 2001 Aug; 86(8):851-5. PubMed ID: 11522542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
    Adcock DM; Johnston M
    Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ASHP therapeutic position statement on the use of the International Normalized Ratio system to monitor oral anticoagulant therapy.
    Am J Health Syst Pharm; 1995 Mar; 52(5):529-31. PubMed ID: 7606561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biological monitoring of treatment with antivitamin K. Value of INR and definition of new therapeutic ranges. A study of 73 patients].
    Gouin I; Horellou MH; Conard J; Samama M
    Arch Mal Coeur Vaiss; 1990 Mar; 83(3):357-61. PubMed ID: 2108630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulant therapy monitoring with international normalized ratio at US academic health centers.
    Yim JM; Albers GW; Vlasses PH
    Ann Pharmacother; 1996 Dec; 30(12):1390-5. PubMed ID: 8968449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of INRs determined with a whole blood prothrombin time device and two international reference preparations for thromboplastin.
    van den Besselaar AM
    Thromb Haemost; 2000 Sep; 84(3):410-2. PubMed ID: 11019963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardization of the prothrombin time in oral anticoagulant control.
    van den Besselaar AM
    Haemostasis; 1985; 15(4):271-7. PubMed ID: 4043828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio?
    Robert A; Chazouillères O
    Hepatology; 1996 Dec; 24(6):1392-4. PubMed ID: 8938167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.